TRPM2 and acute myeloid leukemia: In a Trpm2(-/-) mouse model of AML driven by MLL-AF9, the loss of TRPM2 had neither a substantial effect on the progression of leukemic disease nor a synergistic effect with the cytotoxic therapy (232).